2008 - Fellow of the American Association for the Advancement of Science (AAAS)
His scientific interests lie mostly in Activating transcription factor, Transcription factor, Molecular biology, CREB and DNA-binding protein. His Activating transcription factor research is included under the broader classification of Cell biology. His Transcription factor research is multidisciplinary, relying on both Promoter and Protein degradation.
His Molecular biology study also includes
His primary areas of investigation include Activating transcription factor, ATF3, Transcription factor, Molecular biology and Endocrinology. His study in Activating transcription factor is interdisciplinary in nature, drawing from both Promoter and Cancer research. His ATF3 study combines topics in areas such as Proinflammatory cytokine, Transcription and Immunology.
His study in Complementary DNA extends to Transcription factor with its themes. His studies in Molecular biology integrate themes in fields like Activating transcription factor 2, CAMP Responsive Element Binding Protein, Ccaat-enhancer-binding proteins, Repressor and Response element. His Endocrinology research is multidisciplinary, incorporating elements of Apoptosis, Internal medicine and Signal transduction.
His primary areas of study are ATF3, Internal medicine, Endocrinology, Cancer research and Tumor microenvironment. His research in ATF3 intersects with topics in Regulator, Immunology and Activating transcription factor. His Activating transcription factor research is classified as research in Gene.
His Endocrinology study frequently draws connections between related disciplines such as Prostate cancer. His Cancer research research includes themes of Transforming growth factor, Transcription factor, CREB and Gene knockdown. His Tumor microenvironment research includes elements of Immune modulation, Chemotherapy, Cancer cell, Metastasis and Breast cancer.
The scientist’s investigation covers issues in Cell biology, Tumor necrosis factor alpha, In vivo, Cell cycle and Regeneration. His Tumor necrosis factor alpha research is multidisciplinary, incorporating elements of Metabolite, NFE2L2, Mediator and Immune system. His work deals with themes such as Cell type and Regulatory Pathway, which intersect with NFE2L2.
His research in In vivo intersects with topics in Regenerative process, Angiogenesis, ATF3, Transcriptome and Parabiosis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity.
Tsonwin Hai;Tom Curran.
Proceedings of the National Academy of Sciences of the United States of America (1991)
Transcription factor ATF cDNA clones: an extensive family of leucine zipper proteins able to selectively form DNA-binding heterodimers.
T W Hai;F Liu;W J Coukos;M R Green.
Genes & Development (1989)
The molecular biology and nomenclature of the activating transcription factor/cAMP responsive element binding family of transcription factors: activating transcription factor proteins and homeostasis
Tsonwin Hai;Matthew G Hartman.
Gene (2001)
Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4
Mark Gilchrist;Vesteinn Thorsson;Bin Li;Alistair G. Rust.
Nature (2006)
ATF3 and stress responses.
Tsonwin Hai;Curt D. Wolfgang;Derek K. Marsee;Amy E. Allen.
Gene Expression (1999)
Initiation and execution of lipotoxic ER stress in pancreatic beta-cells.
Daniel A. Cunha;Paul Hekerman;Laurence Ladrière;Angie Bazarra-Castro.
Journal of Cell Science (2008)
Transcription Factor ATF Interacts with the TATA Factor to Facilitate Establishment of a Preinitiation Complex
Masami Horikoshi;Tsonwin Hai;Young-Sun Lin;Michael R. Green.
Cell (1988)
Complexes containing activating transcription factor (ATF)/cAMP-responsive-element-binding protein (CREB) interact with the CCAAT/enhancer-binding protein (C/EBP)-ATF composite site to regulate Gadd153 expression during the stress response.
Timothy W. Fawcett;Jennifer L. Martindale;Kathryn Z. Guyton;Tsonwin Hai.
Biochemical Journal (1999)
Tissue-specific Pattern of Stress Kinase Activation in Ischemic/Reperfused Heart and Kidney
Tinggui Yin;Gulzar Sandhu;Curt D. Wolfgang;Althea Burrier.
Journal of Biological Chemistry (1997)
Activating transcription factor 3 is integral to the eukaryotic initiation factor 2 kinase stress response.
Hao Yuan Jiang;Sheree A. Wek;Barbara C. McGrath;Dan Lu.
Molecular and Cellular Biology (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
The University of Texas Southwestern Medical Center
Salk Institute for Biological Studies
Cedars-Sinai Medical Center
University of Cambridge
University of Massachusetts Medical School
The Ohio State University
Yamaguchi University
The Ohio State University
National Institutes of Health
Rockefeller University
University of Wisconsin–Madison
University of Western Ontario
Iowa State University
Beijing Institute of Technology
Wellcome Sanger Institute
Commonwealth Scientific and Industrial Research Organisation
University of Queensland
Children's Hospital of Los Angeles
Kyoto University
University of the Basque Country
New York University
University of South Florida
Medical University of Graz
Mayo Clinic
Heinrich Heine University Düsseldorf
Rochester Institute of Technology